


Caldan Therapeutics Revenue
Biotechnology Research • Edinburgh, Scotland, United Kingdom • 1-10 Employees
Caldan Therapeutics revenue & valuation
| Annual revenue | $1,000,000 |
| Revenue per employee | $500,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,200,000 |
| Total funding | $1,800,000 |
Key Contact at Caldan Therapeutics
Trond Ulven
Director and Co-Founder
Company overview
| Headquarters | Edinburgh, Scotland, United Kingdom |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2015 |
| Employees | 1-10 |
| Socials |
About Caldan Therapeutics
Caldan, a spin-out company from the Universities of Glasgow and Southern Denmark, is developing novel therapeutics targeting free fatty acid receptors for NASH, Type 2 Diabetes (T2D) and other potential indications. Caldan has arisen from a long-term collaboration between Professor Trond Ulven at the University of Southern Denmark and Professor Graeme Milligan of the University of Glasgow.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Caldan Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Caldan Therapeutics Tech Stack
Discover the technologies and tools that power Caldan Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
JavaScript libraries
Programming languages
Miscellaneous
SEO
CDN
Blogs
Maps
Databases
Miscellaneous
Performance
Frequently asked questions
4.8
40,000 users



